(MENAFN- Ameliorate Digital Consultancy)
The apheresis market refers to the global market for medical devices and services used for apheresis, a process in which blood is removed from a patient, separated into its components (such as plasma, platelets, or white blood cells), and then returned to the patient. Apheresis is used to treat a variety of medical conditions, including immune system disorders, neurological disorders, and blood disorders. The global apheresis market was valued at around $2.2 billion in 2020, and is projected to grow at a compound annual growth rate (cagr) of 8.5% from 2021 to 2028 . Factors driving the growth of the market include increasing prevalence of chronic diseases, rising demand for plasma and platelets for various medical procedures, and increasing awareness and adoption of apheresis treatments in developing countries.
The market is segmented by product type, application, technology, procedure type, end user, and geography. Product types include devices and disposables, while applications include hematology, neurology, nephrology, and others. Technologies used in apheresis include centrifugation, membrane filtration, and others. Procedure types include therapeutic apheresis and donor apheresis. End users include hospitals, blood collection centers, and others.
Key players in the apheresis market include Fresenius Medical Care, Terumo BCT, Inc., Haemonetics Corporation, B. Braun Melsungen AG, Cerus Corporation, Kaneka Corporation, Kawasumi Laboratories, Inc., Therakos, Inc. (a subsidiary of Johnson & Johnson), and Asahi Kasei Medical Co., Ltd.
Get a Free Sample PDF of this Research Report
Key findings of the Apheresis market study:
The report provides a present market outlook on Apheresis. Additionally, the Apheresis market share is anticipated to grow with a CAGR of 11.6% in the forecast period. Regional breakdown of the Apheresis market based on predefined taxonomy. Innovative manufacturing processes implemented by Apheresis vendors in detail. Region-wise and country-wise fragmentation of the Apheresis market to grasp the revenue, and growth outlook in these areas. Changing preferences among consumers across various regions and countries. Factors (Positive and Negative) impacting the growth of the global Apheresis market. Apheresis price, market share, and Trends forecast for assessment period 2022-2032
What is the Growth Scenario of North America Apheresis Markets?
The North America apheresis market is expected to witness significant growth during the forecast period of 2021-2028. Factors driving the growth of the market include increasing prevalence of chronic diseases, rising demand for plasma and platelets for various medical procedures, and increasing awareness and adoption of apheresis treatments in the region. The United States is the largest market in the region, owing to the increasing prevalence of chronic diseases such as cancer, autoimmune diseases, and neurological disorders.
In addition, the rise in demand for plasma and platelets for various medical procedures such as organ transplantations, surgeries, and treatment of bleeding disorders is driving the growth of the apheresis market in North America. Furthermore, increasing awareness about apheresis treatments among patients and healthcare professionals is expected to contribute to market growth.
The market is segmented by product type, application, technology, procedure type, end user, and geography. Product types include devices and disposables, while applications include hematology, neurology, nephrology, and others. Technologies used in apheresis include centrifugation, membrane filtration, and others. Procedure types include therapeutic apheresis and donor apheresis. End users include hospitals, blood collection centers, and others.
Competitive landscape analysis
Key apheresis manufacturers are constantly innovating to meet new challenges that emerge on a daily basis. Leading market participants are focusing on a competitive market pricing strategy that includes the installation of integrated systems as well as high-end software.
Apheresis companies are forming collaborations and partnerships with governments and end-user industries in order to increase the rate of apheresis system installation.
Fresenius Kabi opened a new transfusion and apheresis disposables plant in the Dominican Republic in January 2020. Apheresis sets are manufactured by the company. These items are used to collect blood components such as platelets or plasma. Fresenius Kabi expanded to meet the rising demand for these high-quality disposables used for critical donations. NIKKISO CO., LTD. participated in the China Medical Equipment Fair (CMEF) & International Component Manufacturing Design Show (ICMD) in September 2020, a global exhibition for the medical device market. It will be held in Shanghai from October 19th to 22nd, 2020. In August 2022, Haemonetics Corporation announced a partnership with Epic, a leading Electronic Health Record (EHR) system, to provide Epic's users with Haemonetics' SafeTrace Tx® blood bank information system.
Some of the leading companies operating in the market are :
Terumo Corporation Fresenius Kabi AG B. Braun Melsungen AG NIKKISO Co., Ltd. Medica S. p. A. Asahi Kasei Medical Co. Ltd. Haemonetics Corporation Cerus Corporation Kawasumi Laboratories Inc. Therakos Inc.
What insights does the Apheresis report provide to the readers?
Apheresis fragmentation on the basis of product type, end use, and region. Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape. Collaborations, R&D projects, acquisitions, and product launches of each Apheresis Various regulations imposed by the governments on the consumption of Apheresis in detail.
Key Segments Covered in Apheresis Industry Survey
· By Product :
· By Application :
Renal Diseases Neurology Haematology Cancer Autoimmune Diseases Cardiovascular Diseases Others (Fibrosis and Diabetes)
· By Procedure :
Plasmapheresis Photopheresis LDL Apheresis Plateletpheresis Leukapheresis Erythrocytapheresis Others (Lymphapheresis and extracorporeal immunoadsorption)
· By Technology :
Centrifugation Membrane Filtration
· By End User :
Hospitals Blood Collection Centres
· By Region :
North America Europe Asia Pacific Latin America Middle East &Africa
For in-depth competitive analysis, Buy Now –
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email:
Comments
No comment